Recent developments regarding Avandia

Here are the headlines and links to several stories on Avandia since the recent reports on the FDA panel recommendation to keep it on the market and then reports on possible conflicts of interests of some members of the panel. FDA Halts A Controversial Avandia Study (Pharmalot, July 21) FDA Panel Members Talk About Avandia Conflicts (Pharmalot, July 21) FDA Asks HHS To Probe Avandia Panel Member (Pharmalot, July 26) Investigation Launched into Conflict on Avandia Panel (AboutLawsuits, July 27)